Leelawati Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.43 M
- Company Age 19 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.55 M
About Leelawati Pharma
Leelawati Pharma Private Limited (LPPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 August 2005 and has a history of 19 years and six months. Its registered office is in Seraikela-Kharsawan, Jharkhand, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.43 M.
The company currently has active open charges totaling ₹0.55 M.
Rupa Sinha and Kumar Rajiv serve as directors at the Company.
Company Details
- Location
Seraikela-Kharsawan, Jharkhand, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230JH2005PTC011499
- Company No.
011499
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Aug 2005
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Jharkhand
Industry
Who are the key members and board of directors at Leelawati Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rupa Sinha  | Director | 01-Aug-2005 | Current |
| Kumar Rajiv | Director | 18-Sep-2015 | Current |
Financial Performance of Leelawati Pharma.
Leelawati Pharma Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Leelawati Pharma?
In 2017, Leelawati Pharma had a promoter holding of 50.00% and a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0.55 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.03 Cr
- State Bank Of India Smeccc Jamshedpur : 0.03 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Dec 2011 | State Bank Of India Smeccc Jamshedpur | ₹0.25 M | Open |
| 04 Nov 2011 | State Bank Of India | ₹0.30 M | Open |
How Many Employees Work at Leelawati Pharma?
Unlock and access historical data on people associated with Leelawati Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Leelawati Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Leelawati Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
